What is 3Derm?
3Derm specializes in advanced skin imaging solutions, offering a proprietary system designed to capture high-quality images crucial for enhanced dermatological care. The company extends its services through teledermatology, facilitating effective patient triage and leveraging world-class algorithms for precise skin disease diagnosis. Targeting healthcare providers and organizations, 3Derm aims to revolutionize dermatological practices with its innovative technology. Notably, the company has received FDA Breakthrough Device designations for its autonomous skin cancer AI, highlighting its commitment to cutting-edge diagnostic tools.
How much funding has 3Derm raised?
3Derm has raised a total of $2.8M across 2 funding rounds:
Private Equity
$1.2M
Private Equity
$1.7M
Private Equity (2014): $1.2M, investors not publicly disclosed
Private Equity (2016): $1.7M, investors not publicly disclosed
What's next for 3Derm?
With the recent influx of major strategic investment, 3Derm is well-positioned to accelerate its growth trajectory. The company is expected to further develop its AI-driven diagnostic capabilities and expand its reach within the healthcare provider network. Future initiatives will likely focus on enhancing its teledermatology platform and integrating its advanced imaging solutions into broader clinical workflows. This capital infusion is anticipated to fuel product development, market penetration, and strategic partnerships, solidifying 3Derm's role as a leader in digital dermatology.
See full 3Derm company page
